Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 54.30
-0.50 (-0.91%)
May 8, 2026, 1:30 PM CST
Formosa Laboratories Market Cap
Formosa Laboratories has a market cap or net worth of 6.53 billion as of May 8, 2026. Its market cap has decreased by -4.40% in one year.
Market Cap
6.53B
Enterprise Value
8.56B
Revenue
4.85B
Ranking
n/a
PE Ratio
14.92
Stock Price
54.30
Market Cap Chart
Since March 2, 2011, Formosa Laboratories's market cap has increased from 5.60B to 6.53B, an increase of 16.61%. That is a compound annual growth rate of 1.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 6.53B | -8.43% |
| Dec 31, 2025 | 7.13B | -13.81% |
| Dec 31, 2024 | 8.27B | -32.55% |
| Dec 29, 2023 | 12.27B | 38.78% |
| Dec 30, 2022 | 8.84B | 21.49% |
| Dec 30, 2021 | 7.28B | 43.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.45B |
| Handa Pharmaceuticals | 11.70B |
| Standard Chemical & Pharmaceutical | 10.92B |
| Alar Pharmaceuticals | 9.15B |
| Orient Pharma | 5.81B |
| LIWANLI Innovation | 5.68B |
| SCI Pharmtech | 5.58B |
| Easywell Biomedicals | 4.49B |